Lee, Hae Won <br/><br/>
Bioequivalence of a single 400-mg dose of imatinib 100-mg oral tablets and a 400-mg tablet in healthy adult Korean volunteers.  [electronic resource] 

 -  International journal of clinical pharmacology and therapeutics  Jun 2015 
 - 480-7 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0946-1965 
<br/><br/><label>Standard No.: </label>10.5414/CP202267  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Antineoplastic Agents--administration & dosage<br/>Area Under Curve<br/>Asian People<br/>Benzamides--administration & dosage<br/>Biological Availability<br/>Chromatography, Liquid<br/>Cross-Over Studies<br/>Drug Monitoring<br/>Half-Life<br/>Healthy Volunteers<br/>Humans<br/>Imatinib Mesylate<br/>Male<br/>Metabolic Clearance Rate<br/>Middle Aged<br/>Piperazines--administration & dosage<br/>Protein Kinase Inhibitors--administration & dosage<br/>Pyrimidines--administration & dosage<br/>Republic of Korea<br/>Tablets<br/>Tandem Mass Spectrometry<br/>Therapeutic Equivalency<br/>Young Adult